Want to see OPRX full AI Analyst Report?
OPRX Stock Chart & Stats
$7.17
-$1.11(-19.07%)
At close: 4:00 PM EST
$7.17
-$1.11(-19.07%)
Day’s Range― - ―
52-Week Range$4.57 - $22.25
Previous CloseN/A
Volume200.46K
Average Volume (3M)455.85K
Market Cap
$116.16M
Enterprise Value$98.87M
Total Cash (Recent Filing)$20.17M
Total Debt (Recent Filing)$23.72M
Price to Earnings (P/E)16.9
Beta1.90
Next Earnings
Aug 06, 2026EPS Estimate
0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.36
Shares Outstanding18,765,076
10 Day Avg. Volume279,210
30 Day Avg. Volume455,845
Financial Highlights & Ratios
PEG Ratio-0.35
Price to Book (P/B)1.77
Price to Sales (P/S)2.08
P/FCF Ratio12.19
Enterprise Value/Market Cap0.85
Enterprise Value/Revenue0.92
Enterprise Value/Gross Profit1.33
Enterprise Value/Ebitda5.23
Forecast
1Y Price Target
$12.00Price Target Upside67.36% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)0.94
Revenue Forecast (FY)$97.41M
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet / Low LeverageMinimal debt (debt-to-equity ~0.02) and a sizable equity base reduce financial risk and give management flexibility to fund growth initiatives, absorb client churn, or pursue strategic investments without immediate refinancing pressure. This supports durable capital allocation decisions over 2–6 months.
Sustained Margin And Profitability ImprovementThe company has moved from prior losses to consistent profitability with high gross margins and expanding adjusted EBITDA, driven by lower costs and operational discipline. Higher margins increase free cash generation capacity and make growth investment more sustainable even if top-line is soft near term.
Product Traction, Subscription Mix & Programmatic OpportunityRapid DAP and subscription growth, plus 110% net revenue retention, indicate stronger product-market fit and recurring revenue. Coupled with programmatic/DSP access to underutilized EHR inventory, this provides a scalable, higher-visibility revenue path that can materially improve long-term growth and margin sustainability.
Bears Say
YoY Revenue Decline And Lowered GuidanceA meaningful year-over-year top-line decline and a narrower revenue guidance range signal persistent demand weakness and limited near-term growth visibility. Sustained revenue shortfalls would constrain meaningful reinvestment and make margin gains more dependent on continued cost cuts rather than organic expansion.
Contracted Revenue & Visibility PressureShorter contract durations and MFN-related disruptions have reduced contracted backlog and forward revenue visibility. This structural decline in contracted revenue complicates sales forecasting, weakens renewal leverage with large clients, and delays realization of programmatic and subscription uplift.
Client Concentration Risk And Cash VolatilityDependence on large customers (top-20 = 52% of revenue) and a material client disruption have shown how execution or MFN issues can quickly depress revenue and cash. Recent negative operating cash flow and declining cash balances increase reliance on the revolver and heighten execution risk if new bookings don't materialize.
OptimizeRx News
OPRX FAQ
What was Optimizerx Corporation’s price range in the past 12 months?
Optimizerx Corporation lowest stock price was $4.57 and its highest was $22.25 in the past 12 months.
What is Optimizerx Corporation’s market cap?
Optimizerx Corporation’s market cap is $116.16M.
When is Optimizerx Corporation’s upcoming earnings report date?
Optimizerx Corporation’s upcoming earnings report date is Aug 06, 2026 which is in 32 days.
How were Optimizerx Corporation’s earnings last quarter?
Optimizerx Corporation released its earnings results on May 12, 2026. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.053 by $0.087.
Is Optimizerx Corporation overvalued?
According to Wall Street analysts Optimizerx Corporation’s price is currently Undervalued.
Does Optimizerx Corporation pay dividends?
Optimizerx Corporation does not currently pay dividends.
What is Optimizerx Corporation’s EPS estimate?
Optimizerx Corporation’s EPS estimate is 0.11.
How many shares outstanding does Optimizerx Corporation have?
Optimizerx Corporation has 18,765,076 shares outstanding.
What happened to Optimizerx Corporation’s price movement after its last earnings report?
Optimizerx Corporation reported an EPS of $0.14 in its last earnings report, beating expectations of $0.053. Following the earnings report the stock price went down -22.476%.
Which hedge fund is a major shareholder of Optimizerx Corporation?
Currently, no hedge funds are holding shares in OPRX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
OptimizeRx Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$12.00 (67.36% Upside)
$12.00 (67.36% Upside)
Blogger Sentiment
Bullish
OPRX Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 206.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 4.1%
Last 30 Days ▼ 5.1%
Last 30 Days ▼ 5.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-52.82%
12-Months-Change
Fundamentals
Return on Equity
5.47%
Trailing 12-Months
Asset Growth
-0.30%
Trailing 12-Months
Company Description
Optimizerx Corporation
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.
OPRX Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call balanced encouraging operational and margin progress (strong adjusted EBITDA growth, improved gross margins, significant product traction with DAP and subscription growth, refinancing savings, and KPI improvements) against tangible near-term top-line challenges (10% YoY revenue decline, 15-20% contracted revenue shortfall, a major client disruption, reduced cash and negative operating cash flow, and a downward revision to revenue guidance). Management emphasized these headwinds are short-to-intermediate term and highlighted programmatic/DSP initiatives and subscription mix as drivers for 2027 recovery.View all OPRX earnings summariesOPRX Stock 12 Month Forecast
Average Price Target
$12.00
▲(67.36% Upside)
Technical Analysis
Ownership Overview
7.57% Insiders
15.33% Mutual Funds
30.89% Other Institutional Investors
39.49% Public Companies and
Individual Investors